Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Biochem Parasitol
2009 Feb 01;1632:67-76. doi: 10.1016/j.molbiopara.2008.09.011.
Show Gene links
Show Anatomy links
Two novel nucleobase/pentamidine transporters from Trypanosoma brucei.
Ortiz D
,
Sanchez MA
,
Quecke P
,
Landfear SM
.
???displayArticle.abstract???
African trypanosomes are unable to synthesize purines de novo and must salvage preformed purine nucleosides and nucleobases from their hosts. The Trypanosoma brucei genome project has identified 12 members of the equilibrative nucleoside transporter family, most of which have been characterized previously as nucleoside and/or nucleobase transporters. Here the 11th member of this family, TbNT11.1, has been functionally expressed in null mutants of Leishmania that are deficient in purine nucleoside or nucleobase uptake and identified as a high-affinity purine nucleobase transporter. Expression of TbNT11.1 in Xenopus oocytes revealed that it is also a transporter for the diamidine drug pentamidine that is the principal drug employed to treat early stage human African trypanosomiasis and may thus contribute to the uptake of this therapeutically important compound. In addition, characterization of the 12th member of the family, TbNT12.1, reveals that it is an adenine/pentamidine transporter.
Al-Salabi,
Molecular interactions underlying the unusually high adenosine affinity of a novel Trypanosoma brucei nucleoside transporter.
2007, Pubmed
Al-Salabi,
Molecular interactions underlying the unusually high adenosine affinity of a novel Trypanosoma brucei nucleoside transporter.
2007,
Pubmed
Arriza,
Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family.
1993,
Pubmed
,
Xenbase
Athri,
3D QSAR on a library of heterocyclic diamidine derivatives with antiparasitic activity.
2006,
Pubmed
Basselin,
Pentamidine uptake in Leishmania donovani and Leishmania amazonensis promastigotes and axenic amastigotes.
1996,
Pubmed
Bastin,
A novel epitope tag system to study protein targeting and organelle biogenesis in Trypanosoma brucei.
1996,
Pubmed
Bray,
Pentamidine uptake and resistance in pathogenic protozoa: past, present and future.
2003,
Pubmed
Burchmore,
Cloning, heterologous expression, and in situ characterization of the first high affinity nucleobase transporter from a protozoan.
2003,
Pubmed
,
Xenbase
Caffaro,
Independent and simultaneous translocation of two substrates by a nucleotide sugar transporter.
2006,
Pubmed
Carter,
Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
1993,
Pubmed
Carter,
Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei.
1995,
Pubmed
Cheng,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
1973,
Pubmed
De Koning,
Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: implications for cross-resistance with arsenicals.
2001,
Pubmed
Helms,
Bloodstream form Trypanosoma brucei depend upon multiple metacaspases associated with RAB11-positive endosomes.
2006,
Pubmed
Henriques,
Molecular and functional characterization of the first nucleobase transporter gene from African trypanosomes.
2003,
Pubmed
,
Xenbase
Ivens,
The genome of the kinetoplastid parasite, Leishmania major.
2005,
Pubmed
King,
Nucleoside transporters: from scavengers to novel therapeutic targets.
2006,
Pubmed
Kozak,
Initiation of translation in prokaryotes and eukaryotes.
1999,
Pubmed
Landfear,
Nucleoside and nucleobase transporters in parasitic protozoa.
2004,
Pubmed
Lanteri,
Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance.
2006,
Pubmed
Liu,
Functional characterization of nucleoside transporter gene replacements in Leishmania donovani.
2006,
Pubmed
Marr,
Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis.
1991,
Pubmed
Martinez,
Allopurinol in the treatment of American cutaneous leishmaniasis.
1992,
Pubmed
Mäser,
A nucleoside transporter from Trypanosoma brucei involved in drug resistance.
1999,
Pubmed
Matovu,
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.
2003,
Pubmed
Natto,
Trypanosoma brucei: expression of multiple purine transporters prevents the development of allopurinol resistance.
2005,
Pubmed
Ortiz,
Molecular genetic analysis of purine nucleobase transport in Leishmania major.
2007,
Pubmed
Pfaffl,
A new mathematical model for relative quantification in real-time RT-PCR.
2001,
Pubmed
Robinson,
Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania.
2003,
Pubmed
Sanchez,
Cloning and functional expression of a gene encoding a P1 type nucleoside transporter from Trypanosoma brucei.
1999,
Pubmed
,
Xenbase
Sanchez,
Functional expression and characterization of a purine nucleobase transporter gene from Leishmania major.
2004,
Pubmed
,
Xenbase
Sanchez,
Six related nucleoside/nucleobase transporters from Trypanosoma brucei exhibit distinct biochemical functions.
2002,
Pubmed
,
Xenbase
Sanchez,
A novel purine nucleoside transporter whose expression is up-regulated in the short stumpy form of the Trypanosoma brucei life cycle.
2004,
Pubmed
Sundaram,
Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs.
2001,
Pubmed
,
Xenbase
Valdés,
Transmembrane domain 5 of the LdNT1.1 nucleoside transporter is an amphipathic helix that forms part of the nucleoside translocation pathway.
2004,
Pubmed
,
Xenbase
Vasudevan,
Point mutations in a nucleoside transporter gene from Leishmania donovani confer drug resistance and alter substrate selectivity.
2001,
Pubmed
Wirtz,
A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei.
1999,
Pubmed
